SLC1A2 and Parkinson disease: Taken together, these data show a significant decrease in the expression of the glutamate transporter EAAT2 in the caudate and putamen of LRRK2 G2019S PD patients, and the reduction of EAAT2 levels is associated with increased astrogliosis.